ABBOTT LABORATORIES (ABT) › Shareholders' EquityABBOTT LABORATORIES (ABT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2006: $14.05B2007: $17.82B2008: $17.52B2009: $23.19B2010: $22.77B2011: $24.53B2012: $26.81B2013: $25.27B2014: $21.64B2015: $21.33B2016: $20.72B2017: $31.10B2018: $30.72B2019: $31.30B2020: $33.00B2021: $36.02B2022: $36.91B2023: $38.83B2024: $47.90B2025: $52.77B$52.77B2006Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$52.77B+10.2%2024$47.90B+23.4%2023$38.83B+5.2%2022$36.91B+2.4%2021$36.02B+9.2%2020$33.00B+5.4%2019$31.30B+1.9%2018$30.72B-1.2%2017$31.10B+50.1%2016$20.72B-2.9%2015$21.33B-1.4%2014$21.64B-14.4%2013$25.27B-5.8%2012$26.81B+9.3%2011$24.53B+7.7%2010$22.77B-1.8%2009$23.19B+32.4%2008$17.52B-1.7%2007$17.82B+26.8%2006$14.05B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share